NanoDimension's investment portfolio includes the following companies:
|
 Crocus Technology focuses on the development and manufacturing of MRAMs, based on thermal assisted and current induced magnetic switching. http://www.crocustechnology.com
 BIND Biosciences is an early stage biopharmaceutical company developing therapeutic targeted nanoparticles capable of profoundly improving patients' lives by concentrating drugs in the target tissue while minimizing systemic exposure. http://www.bindbio.com
 Xtellus is a manufacturer of wavelength blockers and wavelength selective switches for reconfigurable optical add/drop multiplexers in fiber-optic networks.
Acquired by Oclaro (Nasdaq: OCLR) on December 17th, 2009.
http://www.xtellus.com
 Selecta is developing nanoparticle-based immunomodulatory drugs for the treatment and preventation of human diseases. http://www.selectabio.com
 SBA Materials is developing functional porous inorganic and inorganic/organic hybrid materials for a wide range of technologies. http://www.sbamaterials.com
|